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Abstract
Artificial RNA molecules with novel functionality have many applications in synthetic
biology, pharmacy and white biotechnology. The de novo design of such devices using
computational methods and prediction tools is a resource-efficient alternative to exper-
imental screening and selection pipelines. In this review, we describe methods common
to many such computational approaches, thoroughly dissect these methods and high-
light open questions for the individual steps. Initially, it is essential to investigate the
biological target system, the regulatory mechanism that will be exploited, as well as
the desired components in order to define design objectives. Subsequent computational
design is needed to combine the selected components and to obtain novel functionality.
This process can usually be split into constrained sequence sampling, the formulation
of an optimization problem and an in silico analysis to narrow down the number of
candidates with respect to secondary goals. Finally, experimental analysis is important
to check whether the defined design objectives are indeed met in the target environ-
ment and detailed characterization experiments should be performed to improve the
mechanistic models and detect missing design requirements.
Keywords: RNA design, rational de novo design, synthetic biology, artificial RNA
devices, mechanistic models, sequence sampling, experimental validation, RNA design
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RiboNucleic Acid (RNA) sequences are the perfect building blocks to reprogram cel-
lular behavior, as they are known to regulate gene expression at almost every step and in
all domains of life. Features like environment-sensing abilities, enzymatic reactivities and
a cost effective in vitro or in vivo synthesis make RNA a Swiss army knife in synthetic
biology and its related fields such as (white) biotechnology and personalized medicine.
Example applications include self-assembling RNA scaffolds either designed to increase
metabolic production by co-localizing related enzymes [1, 2] or to form lattices and
tubular structures mimicking cytoskeletal proteins [3, 4]. Artificial RNA molecules can
also be made to be highly stable by incorporating modified nucleic acid analogs, which
circumvent rapid degradation by RNase enzymes [5]. Early clinical trials utilizing such
molecules as drugs show that RNA-based therapeutics might be an alternative route to
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cure so far untreatable (genetic) diseases [6]. However, these medical applications are
still in their infancy and challenges, such as intracellular delivery across membranes to
target specific tissues, need to be tackled before RNA-based personalized medicine can
become a standard approach, as recently reviewed by Lieberman [6]. Naturally occurring
RNA regulators and the regulatory mechanisms they employ — for instance miRNAs,
riboswitches, trans-activating RNAs and ribozymes — often serve as templates for de-
signing artificial counterparts or to fill specific gaps in the available repertoire of RNA
devices. The diverse set of designed functional mechanisms was extensively reviewed
[7, 8, 9, 10, 6, 11, 12, 13] and thus is not discussed here. Advances in experimental
technologies, such as high-throughput techniques to investigate functional variants or to
determine RNA structure, and in computational biology make RNA design a growing
and fast developing research field.
As summarized by various reviews [14, 15, 16], artificial RNA molecules can be
generated by several experimental strategies, such as selection and screening approaches,
and by computational rational design. In this contribution, we will focus on how rational
de novo design of single- and multi-stable RNA molecules was accomplished in the
literature. Hence, computational methods and experimental strategies to investigate the
designs including their essential interplay are summarized, but we generally disregard
the actual mechanisms of the novel RNAs in this review.
RNA sequence
Sampling algorithms
Filtering, in silico analysis Optimization methods
Design goals
S
ec
on
da
ry
 d
es
ig
n 
go
al
s
Objective evaluation
Terminate optimization?
Mechanistic details
Measured parameters
Design candidates
Quality score
Design constraints
Keep or 
discard solution?
Functional testing,
Experimental analysis
Graphics CC BY-SA 3.0 by GNOME icon artists
Design Model:
• Requirements by biological system
• Properties of RNA components
• Functional mechanism
Figure 1: Overview of a general de novo design process. The initial design model development comprises
a detailed investigation of the biological testing system, how to interface with the target environment,
compile properties and parameters of RNA components to be utilized and drafting the functional mecha-
nism of the overall design. Computational design is necessary to connect components while maintaining
their individual functionality and to gain the desired new capabilities. Software tools require design
constraints and design goals, which are formulated from the model, as input. An iterative optimization
loop of sequence sampling, objective evaluation and decision-making is performed. A subsequent filter-
ing and in silico analysis step helps to include secondary design goals, properties which could not be
taken care of in the optimization procedure. Functional testing and detailed experimental analysis in
the lab are intended to identify working devices and to deliver valuable details and measured parameters
to improve the design model.
We previously argued [17] that attempts to rationally de novo design RNA molecules
frequently follow a common construction that we view as a pipeline, see Figure 1. Ap-
proaches to design RNAs consistently include initial analysis of the biological target
system and the desired components followed by the application of one or more com-
putational methods to derive candidate RNA sequences. Many design approaches also
include further in silico analysis to reduce the list of candidates that must be tested and
characterized in the laboratory. We found many similarities within the various design
studies, for example, which algorithms and computational methods were used as well
as the experimental setup applied for validation and analysis. We therefore decided to
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review the three pipeline steps individually in the subsequent sections, describe how
they were accomplished and highlight state of the art methods and novel ideas.
1. Characterization of the utilized biological system and components
Any rational de novo approach needs a priori knowledge about the relevant biological
systems and components in order to reliably make decisions that finally lead to functional
designs. Missing knowledge about the biological system and components, or premature
design decisions will cause an extended experimental testing phase or might even make
the project unfeasible. Unfortunately, this phase of information gathering is rarely
described in detail. We therefore devote this section to summarizing what kind of
information needs to be collected for a successful RNA design project.
The essential first step of designing functional RNA molecules is a detailed character-
ization of the in vitro or in vivo system in which the RNA must function. Typically, the
novel RNA molecule is designed to interact with its environment in a specific manner.
However, it might also influence — and be influenced by — other factors. Thus, it is
not only important to examine the mechanism and properties of the desired interaction
between the RNA device and its environment, but even more crucial to consider un-
wanted secondary interactions. Examples therefore might be off-target binding of the
artificially designed RNA, interactions with proteins or other molecules, or degradation
by RNases. If known, such disruptive factors can be taken into account at the various
design steps. To decrease such influences during testing and debugging experiments,
in vitro approaches such as the PURE cell-free system [18] and microfluidics devices
[19, 20] can be used to approximate in vivo conditions while utilizing a well-defined
reaction environment.
Moreover, researchers face many design decisions, from whether to use specific re-
porter genes or vector systems, to the selection of auxotrophic markers or resistance
genes, and all these decisions impact the cell, the constructed plasmid and the func-
tionality of the novel RNA device. For example, many strains exist for common model
species, such as Escherichia coli (E. coli) strains like TOP10, DH5α or MG1655. They
exhibit distinct features which affect the applicability of vectors or detection methods.
For instance, TOP10 cells — in contrast to MG1655 or DH5α — combine the inability
to metabolize arabinose with the deletion of the lacZ gene. Thus, TOP10 cells allow
for systems that use arabinose-inducible araBAD-promoters and β-galactosidase as a
reporter system. Therefore, it is important to carefully consider such issues about the
biological testing system before any computation, as these early decisions affect sub-
sequent steps in the project. For example, the sequence context of the vector or the
reporter gene sequence must be taken into account, either directly — as input for design
programs — or indirectly — as secondary design goals. The latter could be seen as good-
to-have goals, where possible design candidates are sorted and filtered by their predicted
RNA-RNA interaction with the context, in this example. Moreover, early decisions such
as bacterial strains constrain what type of experimental analysis and characterization is
possible, as explained in more detail in section 3.
Another example of a parameter which needs to be included as a design goal for the
in silico computations are RNA concentrations. The relative amount of RNAs present
in the cell is critical for proper functionality. This issue is especially crucial when an
artificially introduced RNA must interact with other molecules, e. g., a riboswitch that is
induced by a small RNA. RNA concentrations can be specified by using strong or weak
promoters, whose strength is determined by their affinity for a specific σ-factor or RNA
polymerase. Additionally, gene expression levels are also affected by the copy number
of the chosen vector, which is regulated by the origin of replication (e. g., high copy
ORI pMB1 vs. low copy ORI p15A). When multiple plasmids are used, their origins
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Figure 2: A) Artificial RNA devices with novel functionality are usually constructed by combining
various components, e. g., an aptamer, a ribosome binding site (RBS) and a reporter gene. B) The
various properties of these components, and thus the functionality, need to be provided to computational
models. Directly measured properties of a single sequence (top) — in this example the binding affinity
of the aptamer — fulfills this task, however with no design flexibility for that component. A catalog of
various sequences increases the flexibility (middle), while a dedicated model — constructed or trained
by a big dataset — allows for maximum flexibility, as the properties can be predicted for any arbitrary
sequence.
of replication need to be compatible, as cloning procedures, e. g., for special resistance
mechanisms, otherwise become difficult.
Additionally, during the design phase, information needs to be collected about bi-
ological components which will be part of the novel RNA device such as promoter,
aptamer, catalytic centers, ribosome binding site (RBS) or Shine Dalgarno (SD) se-
quences. The iGEM Registry of Standard Biological Parts is a web resource1 which
collects well-specified standard and interchangeable components that can be used to
design and construct integrated biological systems. Detailed information on these com-
ponents is crucial for computational design. Such properties include structural confor-
mations, essential nucleotides and the reaction mechanism (e. g., activity levels, reaction
rates, binding affinities, ligand chemistry or reaction intermediates). The sequence con-
text of a component is also important, and must be included as component property.
For example, a stretch of consecutive uracil nucleotides in front of a SD sequence can
boost translation initiation [21], while stable structural elements can cause the opposite
effect [22].
In addition to extracting this information from the literature, it is important to per-
form experiments to characterize individual components with respect to the selected
target system, in order to verify their functionality in the novel environment. For ex-
ample, an aptamer needs its ligand binding affinity measured and the binding structure
confirmed in conditions similar to the target environment. These measurements deliver
the valuable sequence to function relations, which are crucial parameters for computa-
tional models (Figure 2).
Many studies created RNA designs by using fixed nucleotide sequences as RNA
components. Random linker regions were then inserted to derive novel functions. For
example, a fixed aptamer sequence with its known binding affinity [23, 24] or an RBS
1http://parts.igem.org/
4
sequence and its translation efficiency [25]. Although this approach provides a perfect
sequence to function mapping for the individual components, it leads to very restrained
flexibility for the computational design algorithms and thus to RNA devices with pre-
sumably bad overall functionality. For more flexibility, components should be described
with as few fixed nucleotide positions as possible. To increase the number of possible
sequences for a component, while still employing a directly measured sequence to func-
tion relation, a catalog of various sequences for the component and their corresponding
function could be used. The in silico design algorithm could then select a component
sequence which fits the overall RNA device best (Figure 2).
Ideally, the desired components are described by an individual mechanistic model
that maps any nucleotide sequence to a functionality score and vice versa, given user-
supplied environmental factors such as temperature (Figure 2B). These models could
be derived through high-throughput experiments and statistical learning or through
extensive experimental characterization. Such models have the big advantage, that we
might be able to predict the function for any given sequence, even for those which were
not directly measured. An impressive example of a successful design approach based on
detailed mechanistic models is the riboswitch design by Espah Borujeni et al. [26]. The
underlying model to estimate translation initiation efficiency has been developed over
years and is reported in several successive publications [27, 28, 22, 29]. Based on this
mechanistic model, they designed riboswitches and accurately predicted their overall
functionality.
Yet, how much flexibility is indeed necessary to obtain good design results depends a
lot on the complexity of the desired functional mechanism and on the degree of novelty.
The latter ranges from small performance improvements of an existing device, where
solutions are likely to be highly similar to a previously established device, to a device
with novel functionality designed completely from scratch.
2. Computational design of RNA molecules
After determining all the details of the target system and the set of components
involved, it is necessary to use computational methods. This design step connects the
selected building blocks and adds additional functionality, e. g., ensuring that the desired
regulation will take place. All of this computational analysis must also take the target
biological environment into account.
Many previous attempts disregarded this step and the designs were assembled by
solely combining fixed sequences for the desired components [30, 31, 32, 23, 24] and
inserting variable regions or changing various nucleotides to achieve the desired func-
tionality. This approach is prone to the generation of dysfunctional devices, as even
single nucleotide mutations can greatly alter the structure [33] and thus disrupt the
functionality of the components. Therefore, after these alterations are introduced, com-
putational prediction is needed to ensure that components still work in the new sequence
context and that they perform as specified by the design goals.
Alternatives to a computational design approach are in vitro and in vivo screening
or selection pipelines [14], where specific component sequences are concatenated with
additional variable or random regions, leading to a mixed pool of different candidates
[34, 35, 36]. Experimental measurement of the overall functionality of the individual de-
vices leads to the elucidation of well-performing candidates. However, these approaches
do not scale well with the complexity of the design mechanisms. Early design decisions,
such as where random regions are placed, which exact component sequences are chosen
or where sequence variability is allowed, will inevitably limit the solution space. Thus,
when bad initial decisions are made, the likelihood of finding optimal devices is limited
or — for complex mechanisms — can be vanishingly small. Furthermore, these screening
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or selection pipelines only allow for the measurement of the overall functionality cou-
pled to a readout mechanism, and not the functionality of the individual components.
If mechanistic insights are desired, additional experimental analysis as outlined in sec-
tion 3 is needed. Moreover, in the absence of a high-throughput readout for the desired
functionality, a screening or selection requires extensive laboratory effort.
In contrast, computational algorithms are capable of testing thousands to billions
of sequence combinations. The predictive power of models allows to evaluate the func-
tionality of any arbitrary sequence, in order to find an optimal overall solution in a
huge solution space. The capabilities of computational approaches are, of course, lim-
ited by the accuracy of the underlying models and parameters. For instance, structure
prediction is only as good as the underlying experimentally measured energy parame-
ters and the actual fold of a molecule might depend on environmental parameters that
are not included in the model. Thus, although computational approaches are powerful
tools to estimate RNA device performance, the predictions certainly need to be verified
experimentally.
2.1. Design goals
Rational design starts by using the previously collected set of requirements, parame-
ters and functional mechanisms to define design objectives which can be understood by
design software and prediction algorithms. Many design programs focus on secondary
structures as their main input, as an RNA’s secondary structure is closely related to its
function. This simplification facilitated the development of many design programs, as it
allowed complicated conditions to be broken into two main design goals, called positive
design and negative design. Positive design means that the target structure must be
thermodynamically stable, while negative design ensures that contrary structures are
less stable and thus less probable in the ensemble of structures. A sequence which folds
into the desired target structure is found, if both conditions are fulfilled.
Early design programs, such as RNAinverse [37], incorporate secondary structure or
features based on the secondary structure as the major design goal [38]. Designing func-
tional RNAs is therefore often reduced to solving the so-called inverse folding problem,
which is the problem of finding a sequence that adopts a given secondary structure as its
most stable, i. e., minimum free energy (MFE), state. Many programs addressed this by
searching for sequences which minimize the distance between the target and the actual
MFE structure [37, 39, 40, 41] or the distance to the desired shape [42]. Zadeh et al. [43]
called this general approach MFE defect optimization and emphasized its limitation: the
probability of the target structure, which is proportional to its Boltzmann factor [44],
can still be small, due to alternative structures with similar stability in the ensemble
of structural conformations. To circumvent this effect, the probability of the target
structure in the ensemble can be directly computed and maximized [37, 45]. Unfortu-
nately, optimizing for this so-called probability defect aims to remove any structure in
the ensemble that is not the exact specified target structure. This way, even very similar
— and thus probably desired neighboring structures — are removed. In contrast, the
ensemble defect, which was implemented as quality measurement in NUPACK:Design
[46], ensures that structures similar to the target are favored, while distant or contrary
structures are prohibited. Even though the latter is a perfect measure to derive robust
single-stable RNA molecules, specifying additional goals might be helpful. For exam-
ple, mutational robustness [42] aims to retain the desired target conformation and thus
the functionality despite sequence mutations. Such design goals are perfectly suited to
built static RNA molecules like transfer RNAs (tRNAs) which should reliably fold into
a single conformation.
However, many applications require that the designed RNAs are able to change their
conformation upon an external signal. Wolfe et al. [47] introduced a reaction pathway
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approach, where the ensemble defect is minimized for multiple RNAs in a reaction well
[48]. The addition of trigger RNA molecules induces structural changes, leading to a
multi-state system by multiple RNA strands. Designing a single RNA molecule which
adopts multiple structural conformations is also possible, but requires more complicated
objective terms, as the ratio and the conversion between the states has to be specified.
A bi-state objective was introduced by Flamm et al. [49] in the switch.pl program and
extended to multi-state by Ho¨ner zu Siederdissen et al. [50] and Hammer et al. [51]. It
maximizes the probabilities of the target structures in the ensemble while keeping the
free energies of the target states similar. Structural change upon an external trigger such
as temperature or the addition of ligands can be achieved by including the external factor
in the various terms of one target state [49, 52]. Flamm et al. [49] proposed objectives
that also design the conformation landscape by defining energy barriers between states
or the energy difference of target states.
Recent studies refrain from solving the inverse folding problem as the only design
objective and thus relying solely on the close structure-to-function relationship of RNA.
They rather specify the characteristics of their desired mechanistic model directly by
including sequence-to-function measurements, crucial properties of the used components
and the desired functional mechanism [53, 54, 55, 56, 57]. These models might still
include structural features required at specific states, but should encompass much more
than structure prediction at the thermodynamic equilibrium. Pyle and Schlick [58] as
well as Carlson and Lucks [59] suggest that the process of co-transcriptional folding
and other kinetically driven events such as temperature change or ligand interaction
should be incorporated directly into the design process. Also 3D structural motifs or 3D
structure prediction could be beneficial due to the closer function relationship. A kinetic
model for co-transcriptional folding and RNA-ligand interaction was recently included
in the ViennaRNA program barriers [60, 61] and could be used to predict this important
design goal. However, a more detailed model usually comes with higher computational
costs and kinetic simulations for thousands of candidate sequences are rarely feasible as
a design objective. Therefore, computationally fast thermodynamic features dominate
current design objectives and more detailed analyses are usually postponed to an in
silico analysis and verification step.
In summary, when formulating design objectives, two conditions are crucial. The
main goals should explicitly ensure that the functionality of the individual components
is not disrupted when combined into a novel RNA device and the overall intended
functionality should be specified as directly as possible.
2.2. Generate a sequence towards design objectives
To obtain a sequence which fulfills the desired goals, various techniques were applied,
including stochastic optimization approaches, constraint programming [62, 63] or lately
also machine learning [64, 65]. Some of them were recently reviewed by Churkin et al.
[38]. Basically, all approaches have in common that they require a method for sequence
generation. As the solution space for RNA sequences is exponentially big, constraints
or weights are applied to exclude solutions that do not have essential properties. Sub-
sequently, the quality of the obtained sequence candidates is evaluated according to
previously specified objectives and a strategy to decide whether to keep or discard a
solution is defined. This strategy might be an advanced optimization algorithm and/or
simple rules on how to sort and filter candidate sequences with respect to certain thresh-
old boundaries.
2.2.1. Generating sequences with given constraints and features
Unconstrained sequence sampling, where one out of four nucleotides is chosen per
position, leads to a search space which is exponentially growing with the sequence length
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(4n, were n is the sequence length). Thus, sequence constraints are usually introduced
to exclude parts of the sequence space. These can be hard constraints such as specific
nucleotide patterns at fixed positions, e. g., for binding motifs and transcription start
sites, as well as soft constraints specifying nucleotide compositions like GC-content or
a coding sequence for specific amino acids. Sampling towards a probabilistic sequence
model could be also applied, e. g., to obtain variable binding motifs. Negative constraints
which aim to avoid sub-sequences, e. g., specific restriction cut sites, in the complete
design are also desirable.
Furthermore, introducing structural constraints is highly beneficial, as they tend to
decrease the search space enormously [50, Fig. 2]. For example, ribozymes, termina-
tors or aptamers need to adopt a specific secondary structure to be functional. Thus,
nucleotides in such a region must be able to form the correct base-pairing pattern. How-
ever, due to the complexity of the underlying problem, we need to distinguish between
the design of single-stable and bi- or multi-stable RNA molecules. Satisfying a single
secondary structure constraint is easy, as interacting nucleotides can be simply picked
from the set of allowed base-pairs at the corresponding positions. In contrast, respecting
multiple structure constraints, maybe even in combination with certain sequence con-
straints, is computationally complex [49, 66]. It is worth noting that crossing base-pairs
such as in pseudo-knots can be easily handled as a structural constraint [67, 51].
The first program that could uniformly sample sequences able to adopt two struc-
tural conformations was switch.pl [49]. The corresponding contribution introduced many
definitions and problem statements which are still an important foundation. Successive
programs — multiSrch [68], Frnakenstein [69] and MODENA 2.0 [67] — then imple-
mented decision tree based enumeration methods which enabled to include more than
two structure constraints. However, it was shown that such methods introduce unde-
sirable sequence biases [51]. Therefore, Ho¨ner zu Siederdissen et al. [50] introduced
a graph-coloring counting algorithm — implemented in RNAblueprint [51] — which
allowed to uniformly draw sequences with respect to multiple structural constraints.
Recently, it has been proven that this problem is #P-hard [66].
As a compatible sequence can – but does not necessarily – fold into the given target
structure(s), it is beneficial to include RNA energy parameters in the sampling procedure
and thereby obtain sequences that are more likely to form the desired base-pairs in
their structural ensemble [39, 40, 70, 66]. Respecting positive design directly in the
sampling procedure was first introduced by Andronescu et al. [39] and implemented in
RNA-SSD . The authors enhanced the RNAinverse algorithm by sampling the initial
seed sequence concerning a probabilistic model to favor low energy target structures.
Subsequently, Busch and Backofen [40] developed a dynamic programming approach for
the seed generation in INFO-RNA to find the sequence that adopts the target structure
with lowest energy possible. The IncaRNAtion approach [70] extended this to achieve
Boltzmann weighted sampling, where a partition function over all sequences given the
target structure is calculated. This allowed global weighted sampling, where sequences
with a stable target structure are more likely to be drawn from the solution space
than others and thus a bias toward the desired solutions is gained. By introducing a
weighting term to adjust the nucleotide content, they got rid of previously observed
GC-biases [70]. However, all these approaches were only capable of generating single-
stable molecules. Only recently, RNAredprint [66] introduced a sampling algorithm
which basically combines and extends the methods of IncaRNAtion and RNAblueprint
[51]. Additionally, RNAredprint allows to include many of the previously mentioned
constraints in an computationally efficient way and thus renders sequence sampling
more powerful.
A different approach to gain similar functionality was introduced with RNAiFold [62]
and its multi-state design successor [63]. The used constraint programming frame-
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work allows to define the desired constraints in a convenient way in terms of pro-
gramming. These include structural constraints as well as sequence soft-constraints
such as compatibility to amino acid sequences. They can be specified either exactly
or based on BLOSUM62 similarity2. However, the generally applicable constraint pro-
gramming framework has the disadvantage of having limited run-time performance, as
the constraint dependencies are getting more complex. Nevertheless, RNAifold allows
to either enumerate all sequences of the solution space or, with the extension of the
Large Neighborhood Search (LNS), to explore unreasonable big solution spaces partially.
RNAredprint as well as RNAifold are able to count the number of possible solutions and
thus report if no sequence exists for the chosen inputs.
2.2.2. Optimization approach for finding desired solutions
By constraining and weighting the sequences during sampling, design goals like the
presence of specific sequence patterns, structure compatibility or even positive design
are achievable. However, more complex goals cannot be directly accomplished yet. A
prominent example is negative design, which aims to get rid of competing states in the en-
semble of structures to achieve high occupancy of the target state(s). Thus, RNA design
is often described as an combinatorial optimization problem, which can be solved by it-
eratively tackling the forward problem, i. e., RNA structure prediction. Such approaches
can be generally dissected into a sequence generation method (subsubsection 2.2.1), an
objective function to evaluate the generated sequences (subsection 2.1), and an opti-
mization strategy which decides whether to keep or reject a generated solution, which
is discussed in the following.
The first design programs mainly used the adaptive walk optimization, where a new
sequence variant is only accepted if it has a better objective score than the currently best
candidate [37, 49]. Zadeh et al. [46] included a rejection list of unfavorable mutations
in NUPACK:Design to save computation time. INFO-RNA and RNA-SSD also accept
worse scoring sequences with a fixed probability to be able to escape local minima
[39, 40]. Simulated annealing, where this acceptance probability decreases during the
optimization run, was implemented in RNAexinv , ARDesigner and RiboMaker [71, 53,
42].
Kleinkauf et al. [72] developed antRNA, a nature inspired ant colony optimization
algorithm. Here, ants traverse a decision tree which lists all allowed nucleotides for each
position of the RNA sequence and leave a pheromone trail depending on the quality of
the overall solution. Successive ants are then weighting their decisions by the pheromone
amount along the trail.
Other nature inspired methods follow principles of evolution theory. A population of
sequences is evolved by applying mutation and recombination to generate new offsprings,
which are subsequently evaluated and selected by their overall fitness. Frnakenstein [69]
implements such a optimization approach and in MODENA a multi-objective genetic
algorithm based on these principles is applied [45, 67]. Only recently, Rubio-Largo
et al. [73] also used evolutionary computation and a multi-objective strategy to op-
timize for standard design goals. Ramlan and Zauner [68] even developed multiple
versions of their design tool with different optimization techniques, including a sorting-
bins multi-objective optimization multiSrch and a non-deterministic stochastic variant
StochSrchMulti .
Although various optimization strategies were applied for the RNA design problem,
there exists to our knowledge no study that compares the efficiency or applicability of
the different methods in equivalent context. The latter would require to use the same
2http://bioinformatics.bc.edu/clotelab/RNAiFold
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sampling method, objective function, and inputs and to vary only the applied optimiza-
tion algorithm to observe the differences in terms of run-time and quality. However, from
the little knowledge about the characteristics of the solution landscapes, it seems that
very simple optimization strategies such as gradient walks are already sufficient. More
insights into the solution landscapes would help to define a proper neighborhood rela-
tionship that connects RNA sequences with similar properties. This could help to find
an efficient way to traverse the solution space. Hammer et al. [51] tested the performance
of optimization runs using different neighborhood relations and step sizes. Interestingly,
a random mixture of small and large step-sizes performed best on a selected set of de-
sign instances. We know that properties of individual sequences are closely connected
to the secondary structure and that the relationship between sequence and structure is
quite complex. Thus, it might be possible to enhance optimization methods by pursu-
ing the studies on sequence structure maps, neutral networks and shape space covering
[33, 74, 75, 76] with respect to RNA design criteria.
2.2.3. Filtering and in silico analysis
Ideally, any design goal can be achieved by solving an optimization problem, which
means that all generated candidates would perfectly fulfill the given requirements. How-
ever, as this is not the case, a subsequent in silico analysis step is often needed for various
reasons. For example, some studies did not use an optimization approach at all and in-
stead enumerated all their candidates. Thus, they rely on such an analysis step to
select solutions by ranking and filtering with respect to certain criteria and threshold
boundaries [23, 24]. Also, according to Garcia-Martin et al. [62], an exhaustive quality
determination is essential after the candidate enumeration step of the applied constraint
programming approach.
A big advantage of this step is the possibility to sort and filter the candidates with
respect to secondary design goals, which could not be included in the main optimiza-
tion approach. These goals might be computationally too demanding to be iteratively
calculated for each candidate sequence during the optimization. Examples are genome
wide off-target searches for designed trans-RNAs or exhaustive kinetic folding experi-
ments [77, 57]. By ranking the solutions accordingly, it is possible to emphasize parts of
the design objectives and choose candidates which fulfill various goals best, an approach
which is similar to solving a posteriori multi-objective problem [78]. There, many Pareto
optimal solutions are generated and the user can choose a posteriori which goal is impor-
tant and thus heavily weighted. Another reason for the necessity of an in silico analysis
step could be that a careful specification of design goals and constraints was missing
and thus an enormous list of computationally generated candidates has been produced.
A ranking and filtering is then the only option to reduce the amount of candidates to a
number that can be handled in the laboratories.
Many of the mentioned tools deliver a complete package to convert the desired fea-
tures of the novel RNA molecule into resulting sequences by doing many complex tasks
on the way. In this section, we dissected these programs, collected and classified the un-
derlying methods, and highlighted the algorithmic advances recently made. As design
problems are usually very diverse, delivering a complete software package with specific
design goals, sampling methods and optimization strategies is not very useful for bio-
logically relevant applications. Thus, we think that computational tools for rational de
novo design only succeed if they are built as software components which can be flexibly
combined to solve a specific design task [51, 57]. It should at least be possible to adapt
the objectives, constraints and other prerequisites of the tools to real world scenarios in
order to serve biologically meaningful applications.
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3. Experimental analysis of the generated candidates
The main goal of the previous computational design was to connect the characterized
components and add novel functionality with respect to the biological target environ-
ment. With functional testing assays, we can investigate whether the candidates exhibit
proper overall performance. However, the causes for frequent discrepancies between
computational predictions and the biological testing results are manifold. Important in-
fluences of the target environment could have been missed in the model, utilized building
blocks might have been disrupted due to the new context, or the model failed to describe
the new mechanism. Detailed biological and biochemical characterization of the novel
RNA device is required to be able to distinguish these aspects and to react by fine tuning
parameters of the computational design or by identifying and including missing design
objectives.
3.1. Functional testing
The experimental strategy for the initial functional evaluation strongly depends on
the basic regulatory mechanism of the device to be tested. In general, RNA-based regu-
lators either adopt alternative structures in order to present or mask certain regulatory
elements (riboswitches) or to fold into an active or inactive ribozyme-based endonuclease
(aptazymes) [79, 12]. A further example is to use trans-acting RNAs that specifically
bind to a target transcript and thereby regulate expression. In the following, we briefly
summarize experimental approaches for the functional testing of such RNA devices.
Testing at the protein level. Synthetic devices — riboswitches, aptazymes, trans-acting
RNAs and others — are usually designed to regulate expression of a certain target
gene. Hence, their overall functionality can be tested using a standard reporter like
green fluorescent protein (GFP), LacZ, auxotrophic or antibiotic resistance markers.
While these genes are easy to handle and give reliable read-outs to measure the re-
sponse ratio of the system, they have certain disadvantages to be considered. Analysis
of GFP expression or other fluorescent proteins is rapid and straightforward, as it can be
monitored without disrupting the cells and even allows for qualitative and quantitative
fluorescence-activated cell sorting (FACS). A LacZ analysis is more labor-intensive, as
suitable cell extracts have to be prepared. If the corresponding enzyme, β-galactosidase,
is expressed, it catalyzes cleavage of ortho-nitrophenyl-β-galactoside into galactose and
ortho-nitrophenol, a yellow reaction product that is easy to quantify. The complex an-
alytic method and considerable fluctuations of the β-galactosidase enzymatic activity
makes GFP — despite a longer protein folding time — more suitable for functional test-
ing. However, both reporter are perfectly suited for quantification [80, 81]. Auxotrophic
and resistance markers can be tested in replica-plating, allowing for rapid selection of
positive/functional constructs but a quantitative analysis of these markers is difficult.
A very different read-out system was used by the Gallivan lab, where functional ribo-
switch constructs regulate the expression of CheZ, a protein involved in chemotaxis. As
a result, active constructs could be identified by the migration of the bacterial host cells
towards the source of the ligand molecule [82].
Testing at the RNA level. In most approaches, riboregulators are designed to control ei-
ther transcription or translation of a certain target RNA. Yet, it is possible that the RNA
construct follows a different regulatory principle than expected [83]. Accordingly, it is
important to identify whether such devices act as intended. To identify regulation at the
RNA level, several approaches are possible. One of the most obvious strategies is North-
ern blot, where specific oligonucleotide or antisense RNA probes identify the expressed
RNA. Depending on the experimental setup, this analysis provides further important
information like expression level and — for instance in the case of aptazyme-mediated
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cleavage — size and abundance of individual RNA fragments. Similarly, quantitative
reverse transcription-polymerase chain reaction (qRT-PCR) can be used to investigate
RNA expression and its turnover. A less labor-intensive approach is the usage of light-up
RNA aptamer sequences as reporter. Here, Systematic Evolution of Ligands by EXpo-
nential enrichment (SELEX)-derived aptamers like Spinach, Broccoli or Mango can be
used that represent functional mimicries of fluorescent proteins [84]. A disadvantage of
light-up RNA aptamers is their rather low sensitivity. To overcome this problem, serial
arrangements of multiple aptamer copies are used [85, 86]. Furthermore, the presence of
high backgrounds that are not observed in vitro necessitate proper control experiments
and complicate the general in vivo applicability [87]. As an alternative, the Ja¨schke
lab developed turn-on aptamers that either bind a fluorophore (like sulforhodamine B)
or a quencher molecule conjugated to a fluorophore. If these ligands interact with the
aptamer, the fluorescence signal strongly increases and can be measured without dis-
rupting the host cell [88, 89]. However, the general applicability as a read-out system
for synthetic RNA regulators still needs to be shown.
Upscaling of functional testing. The described read-out systems for functional RNA-
based regulators are rather limited in terms of the number of samples to be tested.
Computational design approaches can produce hundreds of putative equally good can-
didate sequences and valuable information about their prediction performance can only
be gained if many of them are evaluated experimentally. Hence, it is desirable to test
not only a few candidates but to scale up functional testing to several hundred or more.
FACS is an ideal strategy to do so [35, 90]. However, the applicability of this approach
is currently limited to fluorescence read-out on the protein level, because usage of the
available light-up RNA aptamers suffers from the low sensitivity, as described above. If
microfluidics systems such as the one applied to optimize the Spinach aptamer [20] are
applicable as in vitro proxy needs to be tested.
3.2. Characterization of individual constructs
Independent of the outcome of the functional testing, it is important to understand
and verify the mechanistic basis of the regulation in order to improve the computational
design. Thus, it is mandatory to confirm and quantify the accomplishment of the ini-
tially specified design goals individually, which includes to assess the functionality of any
utilized building block in the new context, to verify the mechanism of newly added func-
tionality and to check for missing indispensable design goals. Especially the latter is a
frequent cause of dysfunctional designs, as there are currently many uncertainties in the
predictions, which include inaccurate or missing model parameters as well as unconsid-
ered influences of the target environment. Frequently missing aspects are degradation,
RNases, RNA binding proteins and chaperones, off-target interactions, tertiary interac-
tions and kinetic or co-transcriptional effects. In the following, we give a short — and
definitely incomplete — overview about currently used investigations.
Structure analysis of RNA devices. In the case of riboswitches or aptazymes, the reg-
ulatory principle is based on the (predicted) structures and their ligand-dependent re-
arrangement. To investigate whether the intended structures are indeed dominating
the structural ensemble in the target environment, several approaches are feasible. The
most straightforward — but restricted to in vitro investigation — is in-line probing.
End-labeled in vitro transcripts are incubated in a buffered solution over a long period
of time, allowing that unpaired nucleotides in single-stranded regions adopt a conforma-
tion where the 2’OH group is in line with the phosphorus atom and the adjacent oxygen
of the neighboring phosphodiester bond. This in-line configuration allows for a nucle-
ophilic attack of the 2’hydroxyl, resulting in a specific cleavage of the single-stranded
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site [91]. Based on the resulting band pattern in polyacrylamide gel electrophoresis,
the structural organization of such transcripts can be identified. Similarly, lead-induced
cleavage can be used to generate band patterns indicative of single-stranded elements,
where the hydrated Pb2+ acts as a Bro¨nsted base and abstracts the proton from the
2’OH in the ribose, rendering it highly nucleophilic. An alternative is SHAPE, where
single-stranded nucleotides are modified by chemical treatment (DMS and NMIA as
examples) and detected by reverse transcription (RT) stops at these positions [92, 93].
While in-line probing can only be used in vitro, lead probing was successfully applied
in vivo for individual transcripts, where the fragile positions were identified based on
primer extensions in reverse transcription. Recently, also structure probing methods for
high-throughput in vivo analyses were established. Methods like SHAPE-Seq, DMS-Seq,
PARS, FragSeq, MOHCA [94, 95, 96, 97, 98] combine the sensitivity of single stranded
RNA for cleavage or modification with massive parallel sequence analysis. While such
approaches are more suited for whole structurome investigations, they can in principle
also be used to determine the structural composition of individual RNA constructs.
An unavoidable fact for a switching RNA molecule is the side by side existence
of multiple structures in the ensemble, which inevitably results in overlapping signals
when structurally analyzed. Yet, based on SHAPE mapping data, a first approach
to identify the individual conformations was recently developed [99], indicating that it
might be possible in the near future to investigate RNA devices with multiple structures
at equilibrium.
Characterization of ligand interaction and recognition. In the case of aptamer-dependent
constructs, it is valuable to identify the actual affinity and interaction with its trigger
molecule in the actual target environment. This includes experiments to verify the pres-
ence of the ligand in the actual reaction compartment, e. g., the bacterial cell. Here,
mostly in vitro investigations are performed, but in vivo approaches might also be ap-
plicable. Again, a rather easy approach is in-line probing in the absence and presence
of the ligand [91]. Originally developed to determine the structure of the ligand-bound
RNA and its affinity in term of Kd, this method can be equally used for riboswitches
[100]. Here, also lead probing as well as in vitro SHAPE should be applicable. Other
approaches like surface plasmon resonance spectroscopy (SPR), electrophoretic mobility
shift assay (EMSA) or microscale thermophoresis (MST) might also be usable. However,
if the interacting ligand is a rather small molecule (as in most cases), the impact on the
mobility of the transcript might be too small to be reliably detected.
Determine RNA stability and degradation. RNA stability and degradation are important
factors when it comes to real-world applications of artificial RNA devices. As they are
often ignored in current design models, detailed information about the stability and
the degradation over time is essential in order to detect undesired effects. Previously
described RNA quantification experiments can also be applied here, such as lifetime
experiments with Northern blot or qRT-PCR. These methods are commonly used to
investigate and measure the RNA decay.
Characterization of the transcript ends. Previously mentioned experiments are not suited
to verify that the complete RNA molecule, from its intended start nucleotide to the end,
is present and appropriate. However, the actually occurring 5’- and 3’-ends of the de-
signed RNA are of specific interest, as they give information about, for example, the
transcription start site, termination site or cleavage positions in an aptazyme. As tran-
scription start sites can differ from promoter to promoter, it is important to identify
the exact sequence composition, since even a single unexpected nucleotide can lead to
misfoldings and loss/reduction of function. The method of choice is 5’- (or 3’-) rapid
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amplification of cDNA-ends (RACE), where in the basic version of the protocol oligonu-
cleotide adapters are ligated to the 5’- (or 3’-) end of the transcript followed by cDNA
synthesis. The resulting product is PCR-amplified by the usage of a target RNA-specific
primer. The adapter-ligation site (corresponding to the RNA end) is then identified by
sequencing. Depending on the actual problem, many different RACE versions are avail-
able for RNA end investigation in prokaryotes as well as eukaryotes [101, 102, 103].
Analysis of kinetic effects. The actual functionality of multi-state RNA devices often
depend on precisely timed kinetic effects, which are typically difficult to comprise in
folding predictions. For example, an intrinsic terminator has to be present at the exact
right time during the transcription process in order to efficiently stop the RNA poly-
merase. A fortiori, experimental examination of intermediate structural conformations
during transcription is necessary to understand the function of many RNA devices,
especially of riboswitches. Although Watters et al. [104] managed to obtain valuable
structural folding information of the crcB fluoride riboswitch during transcription by
utilizing co-transcriptional SHAPE-seq and Helmling et al. [105] successfully applied
NMR spectroscopy to investigate co-transcriptional intermediate structures of the I-A
type 2’dG-sensing riboswitch from Mesoplasma florum, such experiments are tedious
and labor intensive and thus of limited use for design applications. Moreover, for a
proper verification of the ligand-binding model, not only the binding affinity but also
the speed of the reaction — the binding rate — is a crucial factor. Therefore, Schaffer
et al. [106] applied methods like in-line probing and SPR to investigate the kinetics and
thermodynamics of the ligand to AdoCblRiboswitch interaction. Alternative fluorescent
ligands with similar binding behavior and fluorescent nucleobases can be also used to
obtain association rates by stopped-flow fluorescence [107, 108].
Nonetheless, for the purpose of a appropriate cost-benefit ratio, many of these char-
acterization experiments are often spared. If so, at least functional testing assays with
smartly designed control constructs to derive valuable characteristic details of the con-
structed RNA molecules should be performed. For example, proper controls for a tran-
scriptional riboswitch could be a construct which comprises only the terminator or only
the aptamer and the RBS with the otherwise exact same sequence as the designed con-
struct. Also well-considered time series of standard RNA or protein read-out experiments
can deliver important details about intermediates and kinetic effects. Furthermore, if it
is not possible to derive worthwhile information from the characterization experiments,
randomization and a subsequent screening or selection can of course always be applied to
optimize the construct. However, it is important to investigate the optimized constructs
and gain valuable knowledge about their (improved) functionality in order to enhance
the design model for future applications.
4. Conclusion
Rational de novo design always requires some initial knowledge about the functional
mechanism, the characteristics of components and the target environment. For a ri-
boswitch regulating at the transcriptional level, for example, the most obvious needed
information is termination efficiency and mechanics of RNA structural refolding. How-
ever, other information is also important, e. g., ribosomal binding efficiency, which de-
termines translation initiation for reporter gene expression. The combined information
then makes up the functional model, which is part of the overall design goal.
Previously, this information was determined only for specific sequences, which limited
the ability to optimize the overall computational design. The usage of a catalog of
sequences for the individual building blocks will improve this situation to some extent.
Currently, data-driven models are developed to provide enough detail and variability for
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this purpose. However, at the moment such models are rare and rational designs are
often built with little knowledge about the biological environment and the functional
mechanism. To compensate these uncertainties, lots of subsequent laboratory work
is required, such as functional testing and characterization experiments to verify the
functionality of the individual components in the new context. Due to recent advances,
well-designed high-throughput selection and screening pipelines are able to measure
function of many varying RNA sequences, thus producing the amount of standardized
data necessary to built detailed and extensive models [59, 22, 109, 110, 111].
We realized that rational de novo design was sometimes performed without much sup-
port from in silico calculations. We speculated that the reason might be a lack of trust
in the available RNA design tools due to the limitations of computational prediction.
Examples are the inability to consider pseudoknots, the exclusion of non-Watson-Crick
pairings, the often neglected influence of ions in the predictions and models that do not
accurately reflect ligand-RNA interactions. Furthermore, predictions might miss the
structural influences of proteins and organic molecules in the cell and cannot explain
possible structural differences between in vitro and in vivo experiments.
This uncertainty is increased by the frequent lack of experimental verification or real-
world synthetic biology applications. Those are often missing as experiments are time-
consuming and expensive. Instead, the superiority of novel algorithms is often concluded
with extensive benchmarks towards some seemingly arbitrary goals with no obvious bi-
ological applicability. We understand that benchmarking requires standardized inputs
in form of an extensive test set and a precise definition of a perfect solution. These
prerequisites are hard to be fulfilled by laboratory experiments. Nevertheless, in our
opinion, the best benchmark of an RNA design tool is to show its ability to reliably pro-
duce functional RNA devices in real-world settings. NUPACK:Design, for instance, has
been used to implement so-called “toehold” switches [25], small transcription-activating
RNAs [112], small conditional RNAs to regulate RNA interference [113] and to con-
trol the formation of complex nanostructures [114]. The RNAiFold approach has been
adapted and applied to design hammerhead ribozymes [115], regulate internal ribosome
entry site (IRES) activity [116] and to realize temperature-sensitive IRES elements [117].
Thermoswitches have been designed utilizing switch.pl [118]. In most cases, the develop-
ers of the software are among the authors of all these application studies. This indicates
that expert knowledge about the in silico design approach is beneficial for a successful
in vivo implementation.
Of course, it is possible to completely skip computational design and instead utilize
high-throughput screening or selection approaches to obtain complete RNA devices with
the advantage that no model is required [83, 36, 119]. In such studies, the measurement
directly indicates the functionality of the individual devices from the variable pool.
However, the results of these studies do not generalize to other design problems. By
contrast, if appropriate data can be collected in experimental design projects, this data
could provide a basis for a computational model that might accelerate future design
projects. Townshend et al. [120] use a workflow of FACS and next-generation sequencing
to achieve this [121].
On the experimental side, new approaches are needed to be able to measure and verify
important parameters of in silico models in an exact and high-throughput manner. This
would allow the design and validation to form a stronger feedback loop in the design
process, because directly measured data will lead to improved models.
Our vision is that it is possible to quickly and consistently design RNAs with the
desired functionality for their use as artificial logic in gene-regulation, as scaffolding
devices or in therapeutic applications. A fundamental stumbling block is the relative
lack of effective collaboration between computational and experimental scientists. We
believe that the inadequate level of communication between these fields is limiting the
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ability to develop quantitative mechanistic models. Moreover, individual pipeline steps
are developed independently of one another, and thus fail to function optimally together.
Finally, much research is ineffective in promoting progress, because it pursues arbitrary
goals that are not biologically relevant.
To address this problem, there is a need to focus on the practical applicability of
research, including novel algorithms, wet lab techniques and design projects. There is a
need for computational RNA design tools that are useful for their actual purpose, exper-
iments that measure properties needed for in silico models and valuable data generated
when performing screening and selection experiments.
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